[3] BARRIENTOS S, STOJADINOVIC O, GOLINKO M S, et al. Growth factors and cytokines in wound healing[J]. Wound Repair Regen, 2008, 16(5): 585-601.
[4] TANAKA T, NARAZAKI M, KISHIMOTO T. IL-6 in inflammation, immunity, and disease[J]. Cold Spring Harbor Perspectives in Biology, 2014, 6(10): a016295.
[5] OUYANG W, RUTZ S, CRELLIN N K, et al. Regulation and functions of the IL-10 family of cytokines in inflammation and disease[J]. Annual Review of Immunology, 2011, 29: 71-109.
[6] TEIXEIRA D D S, DE FIGUEIREDO M A Z, CHERUBINI K, et al. Topical chlorhexidine, povidone-iodine and erythromycin in the repair of traumatic ulcers on the rat tongue: clinical, histological and microbiological evaluation[J]. Archives of Oral Biology, 2018, 3(87): 218-225.
[9] DOMPE C, MONCRIEFF L, MATYS J, et al. Photobiomodulation-underlying mechanism and clinical applications[J]. Journal of Clinical Medicine, 2020, 9(6): 1724.
[11] LEE H S, LEE Y, JEONG U, et al. Transoral low-level laser therapy via a cylindrical device to treat oral ulcers in a rodent model[J]. Lasers in Surgery and Medicine, 2020, 52(7): 647-652.
[12] KARAVANA HIZARCIOGLU S Y, SEZER B, GUNERI P, et al. Efficacy of topical benzydamine hydrochloride gel on oral mucosal ulcers: an in vivo animal study[J]. International Journal of Oral and Maxillofacial Surgery, 2011, 40(9): 973-978.
[13] YIN J, XIE J, LIN J, et al. Evaluation of the efficacy of the antiulcer oral mucosal protective agent RADoralex® in the prevention and treatment of radiation-induced oral mucosal reactions induced during treatment of nasopharyngeal carcinoma[J]. Cancer Biology and Therapy, 2022, 23(1): 27-33.
[14] RYU H S, LIM N K, PADALHIN A R, et al. Improved healing and macrophage polarization in oral ulcers treated with photobiomodulation (PBM)[J]. Lasers in Surgery and Medicine, 2022, 54(4): 600-610.
[15] ITO M, ONO K, HITOMI S, et al. Prostanoid-dependent spontaneous pain and PAR2-dependent mechanical allodynia following oral mucosal trauma: involvement of TRPV1, TRPA1 and TRPV4[J]. Molecular Pain, 2017, 1(13): 1744806917704138.
[16] COURTOIS E, BOULEFTOUR W, GUY J B, et al. Mechanisms of photobiomodulation (PBM) focused on oral mucositis prevention and treatment: a scoping review[J]. BMC Oral Health, 2021, 21(1): 220.
[17] TANAKA T, NARAZAKI M, MASUDA K, et al. Regulation of IL-6 in immunity and diseases[M]. Regulation of Cytokine Gene Expression in Immunity and Diseases, 2016: 79-88.
[18] SILVA G B L, SACONO N T, OTHON-LEITE A F, et al. Effect of low-level laser therapy on inflammatory mediator release during chemotherapy-induced oral mucositis: a randomized preliminary study[J]. Lasers in Medical Science, 2015, 30(1): 117-126.
[19] NIE F, HAO S, JI Y, et al. Biphasic dose response in the anti-inflammation experiment of PBM[J]. Lasers in Medical Science, 2023, 38(1): 66.
[20] CHEN A C H, HUANG Y Y, ARANY P R, et al. Role of reactive oxygen species in low level light therapy[J]. Mechanisms for Low-light Therapy IV, 2009, 7165: 2-11.
[21] NAJEEB S, KHURSHID Z, ZOHAIB S, et al. Management of recurrent aphthous ulcers using low-level lasers: a systematic review[J]. Medicina, 2016, 52(5): 263-268.
[22] DE SOUSAA M V P. Low-level laser (light) therapy for wound healing in animal models[M]. Hamblin M R. Handbook of low-level laser therapy. New York, Jenny Stanford Publishing. 2016: 18.
[23] PEREIRA F C, PARISI J R, MAGLIONI C B, et al. Antinociceptive effects of low‐level laser therapy at 3 and 8 J/cm2 in a rat model of postoperative pain: possible role of endogenous opioids[J]. Lasers in Surgery and Medicine, 2017, 49(9): 844-851.
[24] MARTINS D, TURNES B, CIDRAL-FILHO F, et al. Light-emitting diode therapy reduces persistent inflammatory pain: role of interleukin 10 and antioxidant enzymes[J]. Neuroscience, 2016, 324: 485-495.
